2015
DOI: 10.1002/ardp.201500363
|View full text |Cite
|
Sign up to set email alerts
|

Design and Synthesis of Substituted Pyridazinone‐1‐Acetylhydrazones as Novel Phosphodiesterase 4 Inhibitors

Abstract: A series of novel pyridazin-6-one-1-acetylhydrazone hybrids were rationally designed to inhibit phosphodiesterase 4 (PDE4B). The prepared compounds were evaluated for their in vitro ability to inhibit the PDE4B enzyme; several of these compounds showed moderate activity compared to the reference drug, rolipram. Compounds 6, 12, and 14 emerged as the most potent inhibitors in this series. The [3-(4-methoxyphenyl)-6-oxo-5,6-dihydro-4H-pyridazin-1-yl]acetic acid [1-(3,4,5-trimethoxyphenyl)ethylidene]hydrazide (12… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 20 publications
0
6
0
Order By: Relevance
“…12,13 More specifically, N-acylhydrazone derivatives have been described as potential inhibitors of COX [14][15][16] , iNOS 17 and phosphodiesterases. 18,19 Lengthening the alkyl chain in the chemical structure of N-acylhydrazone-derived compounds has been identified as a strategy for https://doi.org/10.1016/j.bmc.2018.02.047 0968-0896/Ó 2018 Elsevier Ltd. All rights reserved. drug design and optimization.…”
Section: Introductionmentioning
confidence: 99%
“…12,13 More specifically, N-acylhydrazone derivatives have been described as potential inhibitors of COX [14][15][16] , iNOS 17 and phosphodiesterases. 18,19 Lengthening the alkyl chain in the chemical structure of N-acylhydrazone-derived compounds has been identified as a strategy for https://doi.org/10.1016/j.bmc.2018.02.047 0968-0896/Ó 2018 Elsevier Ltd. All rights reserved. drug design and optimization.…”
Section: Introductionmentioning
confidence: 99%
“…103,104 The combinatorial assembly of functional linkers led to compounds such as 55, in which a phenyl ring is connected to the C4 pyridazine atom. 105 5.g. Methoxy Heteroaromatic-Based PDE4 Inhibitors.…”
Section: Survey Of Pde4 Inhibitorsmentioning
confidence: 99%
“…The ethyl branch at the 6-position of the benzene ring of 52 fits in the lipophilic pockets, while the benzoate extends into the outer solvated space. Replacement of the acetyl carbonyl group with a urea link between 3,5-dichloropyridine and pyridazinone led to compounds 53 and 54 (Figure ), which were shown to be potent, long-acting, and potentially safe inhaled PDE4 inhibitors. , The combinatorial assembly of functional linkers led to compounds such as 55 , in which a phenyl ring is connected to the C4 pyridazine atom …”
Section: Survey Of Pde4 Inhibitorsmentioning
confidence: 99%
“…Various drugs which have NAH structure which has a different activity [4][5][6] . In recent years, several studies have been published regarding the chemistry and bioactive lead scaffolds of N-acylhydrazones, and over time, this subject has grown in importance for the development of new, therapeutically useful bioactive NAH candidates [7][8][9][10][11] Scheme (1): General synthesis of N-Acylhydrazone derivatives ________________________________________________ Egypt. J. Chem.…”
Section: Introductionmentioning
confidence: 99%